Interleukin 27 as a sepsis diagnostic biomarker in critically ill adults.
Interleukin 27 as a sepsis diagnostic biomarker in critically ill adults.
复制标题
DOI:
10.1097/shk.0b013e3182a67632
复制
发表时间:
2013-11
期刊:
影响因子:
--
通讯作者:
Gibot S
中科院分区:
文献类型:
--
作者:
Wong HR;Lindsell CJ;Lahni P;Hart KW;Gibot S
We previously identified interleukin-27 (IL-27) as a sepsis diagnostic biomarker in critically ill children. The current study tested the performance of IL-27 alone and in combination with PCT for diagnosing sepsis in critically ill adults. Serum samples were made available from a prior prospective study of sepsis biomarkers in critically ill adults. The primary analysis used receiver operating characteristic (ROC) curves to evaluate the performance of IL-27 and PCT. Secondary analysis explored IL-27 performance in subgroups of patients with sepsis secondary to lung and non-lung sources of infection. The net reclassification improvement (NRI) was used to estimate the incremental predictive ability of IL-27 compared to PCT alone. Classification and Regression Tree (CART) analysis was used to generate an IL-27- and PCT-based decision tree. There were 145 patients with sepsis and 125 without sepsis. The ROC curve for IL-27 was inferior (area under the curve [AUC]: 0.68; 95% CI: 0.62 – 0.75) to that of PCT (AUC: 0.84; 95% CI: 0.79 – 0.89). Similar findings were observed when comparing patients with a lung source of infection and those without sepsis. For sepsis patients with a non-lung source of infection, adding IL-27 to PCT improved discrimination (NRI = 0.685; p < 0.001). The AUC for the CART-derived decision tree was 0.92 (95% CI: 0.88 – 0.96) and was significantly greater than that of PCT alone. When used in combination with PCT, IL-27 may improve classification of critically ill adults with sepsis secondary to a non-lung source of infection.